CIA
CVS icon

Cladis Investment Advisory’s CVS Health CVS Stock Holding History

Cladis Investment Advisory’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$324K Buy
4,515
+1
+0% +$77 0.18% 118
2025
Q4 		$358K Buy
4,514
+1
+0% +$79 0.2% 109
2025
Q3 		$340K Sell
4,513
-124
-3% -$8.5K 0.19% 115
2025
Q2 		$320K Sell
4,637
-56
-1% -$3.67K 0.2% 109
2025
Q1 		$318K Buy
4,693
+101
+2% +$6.04K 0.23% 101
2024
Q4 		$206K Sell
4,592
-9,477
-67% -$532K 0.15% 122
2024
Q3 		$885K Sell
14,069
-4,523
-24% -$264K 0.61% 52
2024
Q2 		$1.1M Sell
18,592
-803
-4% -$50.2K 0.8% 38
2024
Q1 		$1.55M Sell
19,395
-174
-0.9% -$13.3K 1.14% 23
2023
Q4 		$1.55M Sell
19,569
-4
-0% -$285 1.21% 20
2023
Q3 		$1.37M Buy
19,573
+66
+0.3% +$4.68K 1.2% 23
2023
Q2 		$1.35M Buy
19,507
+976
+5% +$69.4K 1.17% 20
2023
Q1 		$1.38M Sell
18,531
-281
-1% -$23.6K 1.24% 22
2022
Q4 		$1.75M Sell
18,812
-2,666
-12% -$257K 1.74% 11
2022
Q3 		$2.05M Sell
21,478
-95
-0.4% -$9.4K 2.22% 6
2022
Q2 		$2M Sell
21,573
-499
-2% -$48.7K 2% 9
2022
Q1 		$2.23M Sell
22,072
-100
-0.5% -$10.5K 1.81% 8
2021
Q4 		$2.29M Buy
+22,172
New +$2.05M 1.83% 9

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cladis Investment Advisory's CVS Position: Q1 2026 in Review

Cladis Investment Advisory increased its CVS Health (CVS) stake by 0.02% in Q1 2026, buying an estimated $77 and bringing the position to 4,515 shares worth $324K. The position accounts for 0.18% of the portfolio, ranked #118.

Cladis Investment Advisory first reported a position in CVS in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.29M in Q4 2021. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Cladis Investment Advisory held 4,515 shares of CVS Health worth $324K as of Q1 2026.
  • Cladis Investment Advisory bought 1 CVS Health share in Q1 2026, an estimated $77.
  • CVS Health made up 0.18% of Cladis Investment Advisory's portfolio in Q1 2026, its #118 holding.
  • Cladis Investment Advisory first reported a position in CVS Health in Q4 2021 and has held it in 18 quarters since.
  • Cladis Investment Advisory's CVS Health position peaked at $2.29M in Q4 2021.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Cladis Investment Advisory's 13F filing for Q1 2026, filed 15 May 2026.